Replies to post #195661 on Amarin Corp Plc (AMRN)

[relocatedmetsfan]

Still waiting on better Vascepa coverage by insurance companies. As CardioDoc and others have mentioned, patients are turned off if they have to pay $150+ a month for Vascepa, so they turn to $10 a month for generic Lovaza. Insurance companies will lower the tier for Vascepa after label expansion. Then you target convincing doctors to write scripts and produce DTC advertising to have patients start that conversation.

Amarin management knows all of this and has the focus. Just need time to let things play out.

[KevGee59]

Marzan...I made a solid prediction...haha...got lucky!

I say we pass GL in Nrx and Trx...and Market share.

GL is soooooo yesterday! ;-o

KG ;)

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149251882

KG ;)